Mitochondria as a target for neurotoxins and neuroprotective agents

Annals of the New York Academy of Sciences

Volumn 993, Issue , 2003, Pages 334-344

  Bachurin, Sergey O ^a   Shevtsova, Elena P ^a   Kireeva, Elena G ^a   Oxenkrug, Gregory F ^b,c   Sablin, Sergey O ^d  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Selena Pharmaceuticals Inc   (United States)

Author keywords

Apoptosis; Dimebon; Mitochondria; N acetylserotonin; Neurodegeneration; Permeability transition pores; Tacrine

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMYLOID BETA PROTEIN; CYCLOSPORIN A; DIMEBON; MITOCHONDRIAL PERMEABILITY TRANSITION PORE PROTEIN; MITOCHONDRIAL PROTEIN; N ACETYLSEROTONIN; NEUROPROTECTIVE AGENT; NEUROTOXIN; TACRINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL TISSUE; APOPTOSIS; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; ION TRANSPORT; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSONISM; RAT;

ANIMALIA;

EID: 0037713338     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07541.x     Document Type: Conference Paper

References (26)

1. BEAL, M.F. 1998. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366: 211-223.
2. CASSARINO, D.S. & J.P. BENNETT, JR. 1999. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses and cell death in neurodegeneration. Brain Res. Rev. 29: 1-25.
3. BONILLA, E., K. TANJI, et al. 1997. Neurologic and neuropatologic features of mitochondrial encephalomyopathies. In Mitochondria and Free Radicals in Neurodegenerative Diseases. M.F. Beal, N. Howell & I. Bodis-Wollner, Eds.: 271-281. Wiley-Liss, New York.
4. GREEN, D.R. & J.C. REED. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
5. BERNARDI, P. 1999. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 79: 1127-1155.
6. STOUT, A.K. & H.M. RAPHAEL, et al. 1998. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1: 366-373.
7. MATHER, M. & H. ROTTENBERG. 2000. Aging enhances the activation of the permeability transition pore in mitochondria. Biochem. Biophys. Res. Comm. 273: 603-608.
8. +) with mitochondria. Biochem. Biophys. Res. Comm. 159: 983-990.
9. SIMS, N.R. 1990. Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation. J. Neurochem. 55: 698-707.
10. ERDAHL, W.L., R.J. KREBSBACH & D.R. PFEIFFER. 1991. A comparison of phospholipid degradation by oxidation and hydrolysis during the mitochondrial permeability transition. Arch. Biochem. Biophys. 285: 252-260.
11. SEYFRIED, J., F. SOLDNER, et al. 2000, Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC12 cells. Neurochem. Int. 36: 489-497.
12. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta 1453: 49-62.
13. BERMAN, S.B., S.C. WATKINS & T.G. HASTINGS. 2000. Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: evidence for reduced sensitivity of brain mitochondria. Exp. Neurol. 164: 415-425.
14. PIKE, C.J., N. RAMEZAN-ARAB & C.W. COTMAN. 1997. β-Amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. J. Neurochem. 69: 1601-1611.
15. ZHI-XING, Y., K. DRIEU, L.I. SZWEDA & V. PAPADOPOULOS. 1999. Free radicals and lipid peroxidation do not mediate β-amyloid-induced neuronal cell death. Brain Res. 847: 203-210.
16. WOLFLER, A., P.M. ABUJA, et al. 1999. N-Acetylserotonin is a better extra- and intracellular antioxidant than melatonin. FEBS Lett. 449: 206-210.
17. OXENKRUG, G., P. REQUINTINA & S. BACHURIN. 2001. Antioxidant and antiaging activity of N-acetylserotonin and melatonin in the in vivo models. Ann. N.Y. Acad. Sci. 939: 190-199.
18. BACHURIN, S., G. OXENKRUG, et al. 1999. N-Acetylserotonin, melatonin and their derivatives improve cognition and protect against β-amyloid-induced neurotoxicity. Ann. N.Y. Acad. Sci. 890: 156-166.
19. KARBOWNIK, M., E. GITTO, et al. 2001. Relative efficacies of indole antioxidants in reducing autoxidation and iron-induced lipid peroxidation in hamster testes. J. Cell. Biochem. 81: 693-699.
20. GARCYA, J.J., R.J. REITER, et al. 2001. N-Acetylserotonin suppresses hepatic microsomal membrane rigidity associated with lipid peroxidation. Eur. J. Pharm. 428: 169-175.
21. YOUNGLAI, E.V., S.F. PANG & G.M. BROWN. 1986. Effects of different photoperiods on circulating levels of melatonin and N-acetylserotonin in the female rabbit. Acta Endocrinol. 112: 145-149.
22. ABSI, E., A. AYALA, A. MACHADO & J. PARRADO. 2000. Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain. J. Pineal Res. 9: 40-47.
23. BACHURIN, S., N. LERMONTOVA, et al. 1998. Prevention of β-amyloid-induced neurotoxicity by tacrine and dimebon. J. Neurochem. 71(Suppl. 1): S68.
24. XIAO, X.Q., N. TZE-KIN LEE, et al. 2000. Bis(7)-Tacrine, a promising anti-Alzheimer's agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: comparison with tacrine. Neurosci. Lett. 290: 197-200.
25. ROBITZKI, A., A. MACK, et al. 1998. Butyrylcholinesterase antisense transfection increases apoptosis in differentiating retinal reaggregates of the chick embryo. J. Neurochem. 71: 413-420.
26. BACHURIN, S., E. BUKATINA, et al. 2001. Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer. Ann. N.Y. Acad. Sci. 939: 425-435.